News
HAYA Therapeutics, SA, a biotechnology company pioneering precision RNA-guided regulatory genome targeting therapeutics that reprogram disease-driving cell states for rare, common, chronic and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback